Acorda Therapeutics Announces Corporate Restructuring, Management Changes – Business Wire
ARDSLEY, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a corporate restructuring to reduce costs and more closely align operating expenses with expected revenue. The Company also announced changes to its management team. Corporate Restructuring As a result of the restructuring, the Company is reducing headcount by 15%. Most of the reduction in personnel will…